{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T06:34:09Z","timestamp":1775025249122,"version":"3.50.1"},"reference-count":24,"publisher":"Frontiers Media SA","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2014.00217","type":"journal-article","created":{"date-parts":[[2014,9,23]],"date-time":"2014-09-23T13:45:45Z","timestamp":1411479945000},"source":"Crossref","is-referenced-by-count":30,"title":["Randomized controlled trials of iron chelators for the treatment of cardiac siderosis in thalassaemia major"],"prefix":"10.3389","volume":"5","author":[{"given":"A. John","family":"Baksi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dudley J.","family":"Pennell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2014,9,23]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1093\/eurheartj\/ehq106","article-title":"Relation of myocardial T2* to right ventricular function in thalassaemia major.","volume":"31","author":"Alpendurada","year":"2010","journal-title":"italicEur. Heart J.\/italic"},{"issue":"8","key":"B2","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-14-8","article-title":"Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major.","volume":"14","author":"Alpendurada","year":"2012","journal-title":"italicJ. Cardiovasc. Magn. Reson.\/italic"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1053\/euhj.2001.2822","article-title":"Cardiovascular T2* (T2 star) magnetic resonance for the early diagnosis of myocardial iron overload.","volume":"22","author":"Anderson","year":"2001","journal-title":"italicEur. Heart J.\/italic"},{"key":"B4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/S0140-6736(02)09740-4","article-title":"Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia.","volume":"360","author":"Anderson","year":"2002","journal-title":"italicLancet\/italic"},{"key":"B5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/RMR.0000000000000011","article-title":"T2* imaging of the heart: methods, applications, and outcomes.","volume":"23","author":"Baksi","year":"2014","journal-title":"italicTop. Magn. Reson. Imaging\/italic"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.1161\/CIRCULATIONAHA.110.007641","article-title":"On T2* magnetic resonance and cardiac iron.","volume":"123","author":"Carpenter","year":"2011","journal-title":"italicCirculation\/italic"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.3324\/haematol.2013.083634","article-title":"Myocardial Iron in Thalassemia (MINT) Investigators. International survey of T2* cardiovascular magnetic resonance in (-thalassemia major.","volume":"98","author":"Carpenter","year":"2013","journal-title":"italicHaematologica\/italic"},{"key":"B8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.0902-4441.2006.t01-1-EJH3013.x","article-title":"Four-year evaluation of myocardial and liver iron assessed prospectively with serial MRI scans in young patients with beta-thalassaemia major: comparison between different chelation regimens.","volume":"78","author":"Christoforidis","year":"2007","journal-title":"italicEur. J. Haematol.\/italic"},{"key":"B9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1007\/s00277-005-0075-z","article-title":"Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.","volume":"85","author":"Daar","year":"2006","journal-title":"italicAnn. Hematol.\/italic"},{"key":"B10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD004839.pub3","article-title":"Oral deferiprone for iron chelation in people with thalassaemia.","volume":"8","author":"Fisher","year":"2013","journal-title":"italicCochrane Database Syst. Rev.\/italic"},{"key":"B11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bcmd.2005.11.002","article-title":"Iron chelation treatment with combined therapy with deferiprone and deferioxamine: a 12-month trial.","volume":"36","author":"Kattamis","year":"2006","journal-title":"italicBlood Cells Mol. Dis.\/italic"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1161\/CIRCULATIONAHA.109.874487","article-title":"Cardiac T2* magnetic resonance for prediction of cardiac complications in thalassemia major.","volume":"120","author":"Kirk","year":"2009","journal-title":"italicCirculation\/italic"},{"key":"B13","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1080\/03630260600642567","article-title":"Effective combination therapy of deferiprone and deferoxamine for the rapid clearance of excess cardiac iron and the prevention of heart disease in thalassemia. The Protocol of the International Committee on Oral Chelators.","volume":"30","author":"Kolnagou","year":"2006","journal-title":"italicHemoglobin\/italic"},{"key":"B14","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/j.1365-2141.2008.07122.x","article-title":"Influence of iron chelators on myocardial iron and cardiac function in transfusion-dependent thalassaemia: a systematic review and meta-analysis.","volume":"141","author":"Mamtani","year":"2008","journal-title":"italicBr. J. Haematol.\/italic"},{"issue":"42","key":"B15","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance.","volume":"10","author":"Modell","year":"2008","journal-title":"italicJ. Cardiovasc. Magn. Reson.\/italic"},{"key":"B16","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1182\/blood-2005-07-2948","article-title":"Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis.","volume":"107","author":"Pennell","year":"2006","journal-title":"italicBlood\/italic"},{"key":"B17","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1182\/blood-2013-04-497842","article-title":"A 1-year randomized controlled trial of deferasirox vs. deferoxamine for myocardial iron removal in \u00ce\u00b2-thalassemia major (CORDELIA).","volume":"123","author":"Pennell","year":"2014","journal-title":"italicBlood\/italic"},{"key":"B18","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1161\/CIR.0b013e31829b2be6","article-title":"Cardiovascular function and treatmentin \u00ce\u00b2-thalassemia major: a consensus statement from the American Heart Association.","volume":"128","author":"Pennell","year":"2013","journal-title":"italicCirculation\/italic"},{"key":"B19","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1600-0609.2005.00587.x","article-title":"Evaluation of the efficacy of oral deferiprone in beta-thalassemia major by multislice multiecho T2*.","volume":"76","author":"Pepe","year":"2006","journal-title":"italicEur. J. Haematol.\/italic"},{"key":"B20","doi-asserted-by":"publisher","first-page":"41","DOI":"10.3324\/haematol.2009.019042","article-title":"Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.","volume":"96","author":"Pepe","year":"2011","journal-title":"italicHaematologica\/italic"},{"issue":"38","key":"B21","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-15-38","article-title":"Treatment of heart failure in adults with thalassemia major: response in patients randomised to deferoxamine with or without deferiprone.","volume":"15","author":"Porter","year":"2013","journal-title":"italicJ. Cardiovasc. Magn. Reson.\/italic"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1876","DOI":"10.1161\/CIRCULATIONAHA.106.648790","article-title":"A randomized, placebo-controlled, double-blind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance.","volume":"115","author":"Tanner","year":"2007","journal-title":"italicCirculation\/italic"},{"issue":"12","key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/1532-429X-10-12","article-title":"Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.","volume":"10","author":"Tanner","year":"2008","journal-title":"italicJ. Cardiovasc. Magn. Reson.\/italic"},{"issue":"e82662","key":"B24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0082662","article-title":"Comparative efficacy and safety of deferoxamine, deferiprone and deferasirox on severe thalassaemia: a meta-analysis of 16 randomized controlled trials.","volume":"8","author":"Xia","year":"2013","journal-title":"italicPLoS ONE\/italic"}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"deposited":{"date-parts":[[2017,6,22]],"date-time":"2017-06-22T20:53:59Z","timestamp":1498164839000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2014.00217\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,23]]},"references-count":24,"URL":"https:\/\/doi.org\/10.3389\/fphar.2014.00217","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,23]]}}}